General information about company
Scrip code	506854
NSE Symbol
MSEI Symbol
ISIN*	INE639B01015
Name of company	TANFAC INDUSTRIES LIMITED
Type of company
Class of security	Equity
Date of start of financial year	01-04-2023
Date of end of financial year	31-03-2024
Date of board meeting when results were approved	22-04-2024
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	15-04-2024
Description of presentation currency	INR
Level of rounding used in financial results	Lakhs
Reporting Quarter	Yearly
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited	Audited
Segment Reporting	Single segment
Description of single segment	Chemicals
Start date and time of board meeting	22-04-2024 14:00
End date and time of board meeting	22-04-2024 17:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2024	01-04-2023
B	Date of end of reporting period	31-03-2024	31-03-2024
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	10280.51	37814.5
	Other income	206.14	707.93
	Total income	10486.65	38522.43
2	Expenses
(a)	Cost of materials consumed	6267.6	22044.48
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	74.81	36.63
(d)	Employee benefit expense	461.42	2032.82
(e)	Finance costs	16.94	73.03
(f)	Depreciation, depletion and amortisation expense	182.86	700.42
(f)	Other Expenses
1	Power & Fuel	596.83	1995.3
2	Other Expenses	1244.99	4633.77
10
	Total other expenses	1841.82	6629.07
	Total expenses	8845.45	31516.45

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2024	01-04-2023
B	Date of end of reporting period	31-03-2024	31-03-2024
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
3	Total profit before exceptional items and tax	1641.2	7005.98
4	Exceptional items	0	0
5	Total profit before tax	1641.2	7005.98
7	Tax expense
8	Current tax	344.17	1723.91
9	Deferred tax	30.01	34.04
10	Total tax expenses	374.18	1757.95
11	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
14	Net Profit Loss for the period from continuing operations	1267.02	5248.03
15	Profit (loss) from discontinued operations before tax	0	0
16	Tax expense of discontinued operations	0	0
17	Net profit (loss) from discontinued operation after tax	0	0
19	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
21	Total profit (loss) for period	1267.02	5248.03
22	Other comprehensive income net of taxes	8.22	17.4

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2024	01-04-2023
B	Date of end of reporting period	31-03-2024	31-03-2024
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
23	Total Comprehensive Income for the period	1275.24	5265.43
24	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
25	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	0	0
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
26	Details of equity share capital
	Paid-up equity share capital	997.5	997.5
	Face value of equity share capital	10	10
27	Details of debt securities
28	Reserves excluding revaluation reserve		22047.01
29	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	12.7	52.61
	Diluted earnings (loss) per share from continuing operations	12.7	52.61
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	12.7	52.61
	Diluted earnings (loss) per share from continuing and discontinued operations	12.7	52.61
30	Debt equity ratio
31	Debt service coverage ratio
32	Interest service coverage ratio
33	Disclosure of notes on financial results	Textual Information(1)

Text Block

Textual Information(1)

Notes: 1. The above audited results were reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on 22nd April 2024. 2. The company operates in a single segment i.e, Chemicals in India and all other activities evolve around the same. Hence, there is no reportable primary/ secondary segment in accordance with the requirements of Ind AS 108, 'Operating Segments'. 3. # Figures of the last quarter are the balancing figures between audited figures in respect of the full financial year and published year to date reviewed figures upto the 3rd quarter of the relevant financial year. 4. The Board of Directors, in their meeting held on 22nd Apr 2024, had recommended final dividend of Rs.7.00 /- per equity share of face value of Rs.10/- each for the financial year 2023-24 subject to approval by the shareholders in the ensuing Annual General Meeting (Previous Year Rs.6.50/- per Equity Share).. 5. The Board of Directors, at its meeting held on 10th February 2023, had accorded its approval to the Company's expansion project for doubling its existing capacity of Hydrofluoric Acid Plant at Cuddalore at an estimated cost of around Rs.100 Crores to be implemented over the period of 15 to 18 months. The project is currently under implementation. 6. Other Income of Rs. 629.41 Lakhs during the quarter ending March'23 included an amount of Rs.440.90 Lakhs towards Claims admitted by a Raw Material supplier for non-supply of Purchase Order quantity as per the Contract terms. 7.Figures for the previous period / year have been rearranged /reclassified wherever necessary, to correspond with current period / year presentation.

Statement of Asset and Liabilities
Particulars		Current year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2023
Date of end of reporting period		31-03-2024
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	6064.08
	Capital work-in-progress	2910.12
	Investment property	0
	Goodwill	0
	Other intangible assets	0
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	144.82
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	10.31
	Total non-current financial assets	155.13
	Deferred tax assets (net)	0
	Other non-current assets	838.41
	Total non-current assets	9967.74
2	Current assets
	Inventories	5870.61
	Current financial asset
	Current investments	6516.92
	Trade receivables, current	6112.33
	Cash and cash equivalents	712.27
	Bank balance other than cash and cash equivalents	218.75
	Loans, current	0
	Other current financial assets	0.76
	Total current financial assets	13561.03
	Current tax assets (net)	80
	Other current assets	621.62
	Total current assets	20133.26

Statement of Asset and Liabilities
Particulars		Current year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2023
Date of end of reporting period		31-03-2024
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	30101
	Equity and liabilities
	Equity
	Equity attributable to owners of parent
	Equity share capital	997.5
	Other equity	22047.01
	Total equity attributable to owners of parent	23044.51
	Non controlling interest
	Total equity	23044.51
	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current	0
	Other non-current financial liabilities	0
	Total non-current financial liabilities	0
	Provisions, non-current	148.46
	Deferred tax liabilities (net)	352.12
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	500.58
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current	4536.39
	Other current financial liabilities	0
	Total current financial liabilities	4536.39
	Other current liabilities	1873.84
	Provisions, current	127.83
	Current tax liabilities (Net)	17.85
	Deferred government grants, Current	0
	Total current liabilities	6555.91
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	7056.49
	Total equity and liabilites	30101
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-01-2024	01-04-2023
Date of end of reporting period		31-03-2024	31-03-2024
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets
	Net Segment Asset
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities
	Net Segment Liabilities
	Disclosure of notes on segments

Cash flow statement, indirect
Particulars		Year ended (dd-mm-yyyy)
A	Date of start of reporting period	01-04-2023
B	Date of end of reporting period	31-03-2024
C	Whether results are audited or unaudited	Audited
D	Nature of report standalone or consolidated	Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax	7005.98
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs
	Adjustments for decrease (increase) in inventories
	Adjustments for decrease (increase) in trade receivables, current
	Adjustments for decrease (increase) in trade receivables, non-current
	Adjustments for decrease (increase) in other current assets
	Adjustments for decrease (increase) in other non-current assets
	Adjustments for other financial assets, non-current
	Adjustments for other financial assets, current
	Adjustments for other bank balances
	Adjustments for increase (decrease) in trade payables, current
	Adjustments for increase (decrease) in trade payables, non-current
	Adjustments for increase (decrease) in other current liabilities
	Adjustments for increase (decrease) in other non-current liabilities
	Adjustments for depreciation and amortisation expense
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss
	Adjustments for provisions, current
	Adjustments for provisions, non-current
	Adjustments for other financial liabilities, current
	Adjustments for other financial liabilities, non-current
	Adjustments for unrealised foreign exchange losses gains
	Adjustments for dividend income
	Adjustments for interest income
	Adjustments for share-based payments
	Adjustments for fair value losses (gains)
	Adjustments for undistributed profits of associates
	Other adjustments for which cash effects are investing or financing cash flow
	Other adjustments to reconcile profit (loss)
	Other adjustments for non-cash items
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships
	Total adjustments for reconcile profit (loss)
	Net cash flows from (used in) operations	7005.98
	Dividends received
	Interest paid
	Interest received
	Income taxes paid (refund)
	Other inflows (outflows) of cash
	Net cash flows from (used in) operating activities	7005.98
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses
	Cash flows used in obtaining control of subsidiaries or other businesses
	Other cash receipts from sales of equity or debt instruments of other entities
	Other cash payments to acquire equity or debt instruments of other entities
	Other cash receipts from sales of interests in joint ventures
	Other cash payments to acquire interests in joint ventures
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships
	Proceeds from sales of property, plant and equipment
	Purchase of property, plant and equipment
	Proceeds from sales of investment property
	Purchase of investment property
	Proceeds from sales of intangible assets
	Purchase of intangible assets
	Proceeds from sales of intangible assets under development
	Purchase of intangible assets under development
	Proceeds from sales of goodwill
	Purchase of goodwill
	Proceeds from biological assets other than bearer plants
	Purchase of biological assets other than bearer plants
	Proceeds from government grants
	Proceeds from sales of other long-term assets
	Purchase of other long-term assets
	Cash advances and loans made to other parties
	Cash receipts from repayment of advances and loans made to other parties
	Cash payments for future contracts, forward contracts, option contracts and swap contracts
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts
	Dividends received
	Interest received
	Income taxes paid (refund)
	Other inflows (outflows) of cash
	Net cash flows from (used in) investing activities
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries
	Payments from changes in ownership interests in subsidiaries
	Proceeds from issuing shares
	Proceeds from issuing other equity instruments
	Payments to acquire or redeem entity's shares
	Payments of other equity instruments
	Proceeds from exercise of stock options
	Proceeds from issuing debentures notes bonds etc
	Proceeds from borrowings
	Repayments of borrowings
	Payments of finance lease liabilities
	Payments of lease liabilities
	Dividends paid
	Interest paid
	Income taxes paid (refund)
	Other inflows (outflows) of cash
	Net cash flows from (used in) financing activities
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes	7005.98
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents
	Net increase (decrease) in cash and cash equivalents	7005.98
	Cash and cash equivalents cash flow statement at beginning of period
	Cash and cash equivalents cash flow statement at end of period	7005.98